TherapeuticsMD (TXMD) Non-Current Debt (2010 - 2021)
TherapeuticsMD's (TXMD) quarterly Non-Current Debt came in at $171.7 million in Q3 2021, down 27.55% YoY from $237.1 million in Q3 2020, and down 2.01% on a QoQ basis from $175.3 million in Q2 2021.
TherapeuticsMD (TXMD) Non-Current Debt (2010 - 2021) Analysis & Trends
TherapeuticsMD (TXMD) has 7 years of Non-Current Debt data on file, last reported at $171.7 million in Q3 2021.
- Quarterly Non-Current Debt fell 27.55% year-over-year to $171.7 million in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $171.7 million (down 27.55% YoY) and the FY2020 annual result came in at $237.7 million, up 22.13% from the prior year.
- Non-Current Debt eased to $171.7 million in Q3 2021, from $175.3 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $243.8 million in Q2 2020 to a low of $73.1 million in Q2 2018.
- A 4-year average of $169.2 million and a median of $189.0 million in 2019 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2020 — Non-Current Debt jumped 231.19% — and 2021, when it declined 28.11%.
- Tracing TXMD's Non-Current Debt over 4 years: stood at $73.4 million in 2018, then soared by 165.24% to $194.6 million in 2019, then grew by 22.13% to $237.7 million in 2020, then retreated by 27.75% to $171.7 million in 2021.
- The last three Non-Current Debt figures came in at $171.7 million (Q3 2021), $175.3 million (Q2 2021), and $184.0 million (Q1 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 130.00 Mn |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 171.74 Mn |
| Jun 30, 2021 | 175.26 Mn |
| Mar 31, 2021 | 183.97 Mn |
| Dec 31, 2020 | 237.70 Mn |
| Sep 30, 2020 | 237.05 Mn |
| Jun 30, 2020 | 243.80 Mn |
| Mar 31, 2020 | 243.43 Mn |
| Dec 31, 2019 | 194.63 Mn |
| Sep 30, 2019 | 194.36 Mn |
| Jun 30, 2019 | 194.10 Mn |
| Mar 31, 2019 | 73.50 Mn |
| Dec 31, 2018 | 73.38 Mn |
| Sep 30, 2018 | 73.26 Mn |
| Jun 30, 2018 | 73.14 Mn |
| Dec 31, 2012 | 3.59 Mn |
| Sep 30, 2012 | 3.10 Mn |
| Jun 30, 2012 | 3.09 Mn |
| Mar 31, 2012 | 2.21 Mn |
| Dec 31, 2011 | 534,160.00 |
| Dec 31, 2010 | 210,000.00 |